Insider · CIK 0001333516

Tsuchimoto Kim R

Reports to the SEC for 4 companies · WILMETTE, IL

sec.gov

Transactions

Companies

Filings

CIK

0001333516

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-26	MNPRMonopar TherapeuticsS Sale	Director	SSale	−485 sh	$108.83	−$52.8K	11,001
2026-08-26	MNPRMonopar TherapeuticsS Sale	Director	SSale	−1,098 sh	$111.84	−$123K	1,192
2026-08-26	MNPRMonopar TherapeuticsS Sale	Director	SSale	−700 sh	$110.65	−$77.5K	9,686
2026-08-26	MNPRMonopar TherapeuticsS Sale	Director	SSale	−1,098 sh	$111.84	−$123K	8,588
2026-08-26	MNPRMonopar TherapeuticsS Sale	Director	SSale	−615 sh	$109.56	−$67.4K	10,386
2026-08-26	MNPRMonopar TherapeuticsS Sale	Director	SSale	−590 sh	$113.84	−$67.2K	0
2026-08-26	MNPRMonopar Therapeutics · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	+2,055 sh	—	—	6,165
2026-08-26	MNPRMonopar TherapeuticsS Sale	Director	SSale	−602 sh	$112.93	−$68K	590
2026-08-26	MNPRMonopar Therapeutics · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	+2,035 sh	—	—	8,140
2026-08-26	MNPRMonopar TherapeuticsS Sale	Director	SSale	−590 sh	$113.84	−$67.2K	7,396
2026-08-26	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+2,055 sh	$30.00	+$61.7K	2,055
2026-08-26	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+2,035 sh	$14.00	+$28.5K	4,090
2026-08-26	MNPRMonopar TherapeuticsS Sale	Director	SSale	−615 sh	$109.56	−$67.4K	2,990
2026-08-26	MNPRMonopar TherapeuticsS Sale	Director	SSale	−602 sh	$112.93	−$68K	7,986
2026-08-26	MNPRMonopar TherapeuticsS Sale	Director	SSale	−700 sh	$110.65	−$77.5K	2,290
2026-08-26	MNPRMonopar TherapeuticsS Sale	Director	SSale	−485 sh	$108.83	−$52.8K	3,605
2025-12-02	MNPRMonopar Therapeutics · Stock OptionsA Award	Director	AAward	+2,924 sh	—	—	2,924
2025-07-14	MNPRMonopar TherapeuticsX Exercise of In-Money	Director	XExercise of In-Money	+8,904 sh	$0.01	+$44.52	20,390
2025-07-14	MNPRMonopar Therapeutics · Stock OptionsX Exercise of In-Money	Director	XExercise of In-Money	−4,200 sh	—	—	0
2025-07-14	MNPRMonopar Therapeutics · Stock OptionsX Exercise of In-Money	Director	XExercise of In-Money	−4,704 sh	—	—	0
2025-07-14	MNPRMonopar TherapeuticsS Sale	Director	SSale	−8,904 sh	$40.00	−$356K	11,486
2025-03-04	MNPRMonopar Therapeutics · Stock OptionsA Award	Director	AAward	+11.4K sh	—	—	11,365
2024-06-30	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−9,957 sh	—	—	74,412
2024-06-30	MNPRMonopar TherapeuticsF Tax Payment	Director	FTax Payment	−2,998 sh	$0.73	−$2,191.538	57,429
2024-06-30	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+9,957 sh	—	—	60,427
2024-03-31	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+9,956 sh	—	—	54,552
2024-03-31	MNPRMonopar TherapeuticsF Tax Payment	Director	FTax Payment	−4,082 sh	$0.68	−$2,779.842	50,470
2024-03-31	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−9,956 sh	—	—	84,369
2024-01-01	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,231 sh	—	—	94,325
2024-01-01	MNPRMonopar TherapeuticsF Tax Payment	Director	FTax Payment	−505 sh	$0.34	−$171.801	44,596
2024-01-01	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+1,231 sh	—	—	45,101
2023-12-31	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−9,957 sh	—	—	95,556
2023-12-31	MNPRMonopar TherapeuticsF Tax Payment	Director	FTax Payment	−4,073 sh	$0.34	−$1,385.635	43,870
2023-12-31	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+9,957 sh	—	—	47,943
2023-09-30	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+9,956 sh	—	—	41,430
2023-09-30	MNPRMonopar TherapeuticsF Tax Payment	Director	FTax Payment	−3,444 sh	$0.62	−$2,134.936	37,986
2023-09-30	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−9,956 sh	—	—	105,513
2023-06-30	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+14.8K sh	—	—	36,578
2023-06-30	MNPRMonopar TherapeuticsF Tax Payment	Director	FTax Payment	−5,104 sh	$0.85	−$4,363.92	31,474
2023-06-30	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−14.8K sh	—	—	115,469
2023-03-31	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−5,067 sh	—	—	130,315
2023-03-31	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+5,067 sh	—	—	23,574
2023-03-31	MNPRMonopar TherapeuticsF Tax Payment	Director	FTax Payment	−1,842 sh	$1.39	−$2,560.38	21,732
2023-02-01	MNPRMonopar Therapeutics · Stock OptionsA Award	Director	AAward	+103K sh	—	—	102,688
2023-02-01	MNPRMonopar Therapeutics · Restricted Stock UnitsA Award	Director	AAward	+78.2K sh	—	—	135,382
2023-01-01	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,230 sh	—	—	1,231
2023-01-01	MNPRMonopar TherapeuticsF Tax Payment	Director	FTax Payment	−502 sh	$2.37	−$1,189.74	18,507
2023-01-01	MNPRMonopar TherapeuticsM Exercise/Conversion	Director	MExercise/Conversion	+1,230 sh	—	—	19,009
2022-12-31	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−5,067 sh	—	—	55,917
2022-12-31	MNPRMonopar TherapeuticsF Tax Payment	Director	FTax Payment	−2,067 sh	$2.37	−$4,898.79	17,779

Recent filings

Accepted (ET)
Aug 284/A
Tsuchimoto Kim R0001437749-26-029235
SEC(opens sec.gov)
Aug 274
Tsuchimoto Kim R0001437749-26-029116
SEC(opens sec.gov)
Dec 84
Tsuchimoto Kim R0001437749-25-037165
SEC(opens sec.gov)
Jul 164
Tsuchimoto Kim R0001437749-25-022863
SEC(opens sec.gov)

Companies

Address

1000 SKOKIE BLVD SUITE 350

WILMETTE, IL, 60091